Literature DB >> 32157302

Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency.

Arianna Troilo1, Claudia Wehr2, Iga Janowska1, Nils Venhoff1, Jens Thiel1, Justyna Rawluk2, Natalie Frede1, Julian Staniek1,3, Raquel Lorenzetti1, Marei-Theresa Schleyer1, Georg W Herget4, Lukas Konstantinidis4, Miriam Erlacher5, Michele Proietti6, Nadezhda Camacho-Ordonez6, Reinhard Edmund Voll1, Bodo Grimbacher6,7,8,9, Klaus Warnatz1,6, Ulrich Salzer1, Marta Rizzi1,10.   

Abstract

Common variable immunodeficiency (CVID) is a disease characterized by increased susceptibility to infections, hypogammaglobulinemia, and immune dysregulation. Although CVID is thought to be a disorder of the peripheral B-cell compartment, in 25% of patients, early B-cell development in the bone marrow is impaired. Because poor B-cell reconstitution after hematopoietic stem cell transplantation has been observed, we hypothesized that in some patients the bone marrow environment is not permissive to B-cell development. Studying the differentiation dynamics of bone marrow-derived CD34+ cells into immature B cells in vitro allowed us to distinguish patients with B-cell intrinsic defects and patients with a nonpermissive bone marrow environment. In the former, immature B cells did not develop and in the latter CD34+ cells differentiated into immature cells in vitro, but less efficiently in vivo. In a further group of patients, the uncommitted precursors were unable to support the constant development of B cells in vitro, indicating a possible low frequency or exhaustion of the precursor population. Hematopoietic stem cell transplantation would result in normal B-cell repopulation in case of intrinsic B-cell defect, but in defective B-cell repopulation in a nonpermissive environment. Our study points to the importance of the bone marrow niche in the pathogenesis of CVID.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32157302      PMCID: PMC7195542          DOI: 10.1182/blood.2019003855

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  A feeder-free differentiation system identifies autonomously proliferating B cell precursors in human bone marrow.

Authors:  Helene Kraus; Sandra Kaiser; Konrad Aumann; Peter Bönelt; Ulrich Salzer; Dietmar Vestweber; Miriam Erlacher; Mirjam Kunze; Meike Burger; Kathrin Pieper; Heiko Sic; Antonius Rolink; Hermann Eibel; Marta Rizzi
Journal:  J Immunol       Date:  2013-12-30       Impact factor: 5.422

Review 2.  Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Authors:  Rajesh Somasundaram; Mahadesh A J Prasad; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2015-05-19       Impact factor: 22.113

3.  Morbidity and mortality in common variable immune deficiency over 4 decades.

Authors:  Elena S Resnick; Erin L Moshier; James H Godbold; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

4.  Letter: B lymphocyte precursors in bone-marrow in immunoglobulin deficiency diseases.

Authors:  L B Vogler; E R Pearl; W E Gathings; A R Lawton; M D Cooper
Journal:  Lancet       Date:  1976-08-14       Impact factor: 79.321

5.  Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis.

Authors:  Yoshiki Nakamori; Bing Liu; Kohshi Ohishi; Kei Suzuki; Kazuko Ino; Takeshi Matsumoto; Masahiro Masuya; Hiroyoshi Nishikawa; Hiroshi Shiku; Hirofumi Hamada; Naoyuki Katayama
Journal:  Br J Haematol       Date:  2012-03-30       Impact factor: 6.998

Review 6.  The role of genomics in common variable immunodeficiency disorders.

Authors:  A-K Kienzler; C E Hargreaves; S Y Patel
Journal:  Clin Exp Immunol       Date:  2017-03-29       Impact factor: 4.330

7.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination.

Authors:  J C Pui; D Allman; L Xu; S DeRocco; F G Karnell; S Bakkour; J Y Lee; T Kadesch; R R Hardy; J C Aster; W S Pear
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

8.  Regulation of human B lymphopoiesis by the transforming growth factor-beta superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment.

Authors:  Michiko Ichii; Kenji Oritani; Takafumi Yokota; Makoto Nishida; Isao Takahashi; Takahiro Shirogane; Sachiko Ezoe; Norimitsu Saitoh; Rie Tanigawa; Paul W Kincade; Yuzuru Kanakura
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

9.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

10.  Stage-specific control of early B cell development by the transcription factor Ikaros.

Authors:  Tanja A Schwickert; Hiromi Tagoh; Sinan Gültekin; Aleksandar Dakic; Elin Axelsson; Martina Minnich; Anja Ebert; Barbara Werner; Mareike Roth; Luisa Cimmino; Ross A Dickins; Johannes Zuber; Markus Jaritz; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2014-02-09       Impact factor: 25.606

View more
  3 in total

1.  Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic.

Authors:  Federica Pulvirenti; Francesco Cinetto; Cinzia Milito; Livia Bonanni; Anna Maria Pesce; Giorgia Leodori; Giulia Garzi; Marzia Miglionico; Stefano Tabolli; Isabella Quinti
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-09

2.  Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools.

Authors:  Lucía Del Pino-Molina; Eduardo López-Granados; Quentin Lecrevisse; Juan Torres Canizales; Martín Pérez-Andrés; Elena Blanco; Marjolein Wentink; Carolien Bonroy; Jana Nechvatalova; Tomas Milota; Anne-Kathrin Kienzler; Jan Philippé; Ana E Sousa; Mirjam van der Burg; Tomas Kalina; Jacques J M van Dongen; Alberto Orfao
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

3.  Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.

Authors:  Olivia A C Lamers; Bas M Smits; Helen Louisa Leavis; Godelieve J de Bree; Charlotte Cunningham-Rundles; Virgil A S H Dalm; Hsi-En Ho; John R Hurst; Hanna IJspeert; Sabine M P J Prevaes; Alex Robinson; Astrid C van Stigt; Suzanne Terheggen-Lagro; Annick A J M van de Ven; Klaus Warnatz; Janneke H H M van de Wijgert; Joris van Montfrans
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.